MYOGEN INC License Agreements
20 Contracts & Agreements
- Form of License, Development and Commercialization Agreement (Filed With SEC on August 9, 2006)
- Form of License, Development and Commercialization Agreement (Filed With SEC on August 9, 2006)
- License Agreement with Glaxo Group Limited (Filed With SEC on May 9, 2006)
- Form of License, Development and Commercialization Agreement (Filed With SEC on May 26, 2005)
- Third Amendment to the License Agreement by and between Aventis Pharmaceuticals, Inc. and Myogen (Filed With SEC on March 15, 2005)
- Patent License Agreement (Filed With SEC on March 1, 2004)
- Third Amendment to Property License Agreement (Filed With SEC on March 1, 2004)
- EX-10.25 License and Development Agreement (Filed With SEC on October 28, 2003)
- EX-10.23 License Agreement: Abbott Laboratories (Filed With SEC on October 28, 2003)
- EX-10.22 Exclusive Patent and Technology License (Filed With SEC on October 28, 2003)
- EX-10.21 Patent and Technology License Agreement (Filed With SEC on October 28, 2003)
- EX-10.19 Intellectual Property License Agreement (Filed With SEC on October 28, 2003)
- EX-10.18 License Agreement: Abbott Deutschland (Filed With SEC on October 28, 2003)
- EX-10.17 License Agreement: Hoechst M. Roussel Inc (Filed With SEC on October 28, 2003)
- EX-10.25 License, Development Agreement (Filed With SEC on October 9, 2003)
- EX-10.23 License Agrmt (Filed With SEC on August 28, 2003)
- EX-10.21 Patent & Technology License Agrmt (Filed With SEC on August 28, 2003)
- EX-10.19 Intellectual Property License Agrmt (Filed With SEC on August 28, 2003)
- EX-10.18 License Agrmt (Filed With SEC on August 28, 2003)
- EX-10.17 License Agrmt (Filed With SEC on August 28, 2003)
